Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Autoimmune Diseases × Infliximab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 4 Crohn Disease 4 Carcinoma, Non-Small-Cell Lung 4 Lung Neoplasms 3 Inflammatory Bowel Diseases 3 Colitis, Ulcerative 3 Colitis 3 Arthritis, Rheumatoid 3 Urogenital Neoplasms 2 Hematologic Neoplasms 2 Depressive Disorder, Major 2 Depression 2 Cachexia 2 Anorexia 2 Vasculitis 1 Takayasu Arteritis 1 Syndrome 1 Stroke 1 Stevens-Johnson Syndrome 1 Skin Neoplasms 1 Rare Diseases 1 Pemphigoid, Benign Mucous Membrane 1 Pancreatic Neoplasms 1 Lymphoma 1 Kidney Transplantation 1 Inflammation 1 Granulomatous Disease, Chronic 1 Graft vs Host Disease 1 Gastrointestinal Diseases 1 Fatigue 1

Interventions

telitacicept 3 fludarabine 3 Prednisone 3 Cyclophosphamide 3 Specimen Handling 2 Nivolumab 2 Antilymphocyte Serum 2 thymoglobulin 1 remdesivir 1 prednylidene 1 deltacortene 1 carmustine, poliferprosan 20 drug combination 1 Vitamin D 1 Valsartan 1 Pyridostigmine Bromide 1 Population Groups 1 Plasma Exchange 1 Peripheral Blood Stem Cell Transplantation 1 Music Therapy 1 Melphalan 1 Infliximab 1 Immunoglobulins, Intravenous 1 Hydroxychloroquine 1 Fish Oils 1 Fatty Acids, Omega-3 1 Etoposide 1 Etanercept 1 Eicosapentaenoic Acid 1 Docosahexaenoic Acids 1 Cytarabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01793519 2024-02-28

STARA

Georgetown University

Phase 4 Unknown

Arthritis, Rheumatoid, Autoimmune Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡